Neurodegenerative Care Strategy Advisor - Healthcare Executive Advisory Board Member

About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID. This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols. Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S. Why Now? Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March. In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers. Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline. FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s. Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:

https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Neurodegenerative Care Strategy Advisor Job Description ATCA is seeking a senior Neurodegenerative Care Strategy Advisor to join its Medical Advisory Board and support the strategic design, refinement, and scaling of care models for Alzheimer’s disease and related neurodegenerative conditions. This role is designed for experienced clinicians, physician-leaders, or healthcare strategists with deep expertise in neurodegenerative disease management and longitudinal care delivery. As a Neurodegenerative Care Strategy Advisor, you will help guide how ATCA structures treatment pathways, clinical decision-making, and long-term care strategies to address complex, progressive neurological conditions at scale. You will work closely with ATCA’s executive leadership, clinical teams, and research collaborators to ensure that care strategies reflect best-in-class neurodegenerative practice while remaining operationally scalable across a national clinic network. Responsibilities Include Neurodegenerative Care Strategy: Provide expert guidance on strategic approaches to treating Alzheimer’s disease, dementia, and related neurodegenerative conditions across multiple stages of progression. Care Pathway Design: Advise on the development of standardized yet flexible care pathways that support early detection, intervention, treatment optimization, and longitudinal management. Precision Medicine Integration: Guide how biomarkers, imaging, cognitive assessments, and patient history inform personalized treatment strategies within ATCA’s AI-driven platform. Clinical Outcomes & Quality Oversight: Review aggregated, de-identified outcomes data to ensure clinical effectiveness, safety, and continuous improvement in neurodegenerative care delivery. Interdisciplinary Alignment: Collaborate with neurologists, pharmacists, technologists, and executive leadership to align neurodegenerative strategy with operational execution. Innovation & Research Translation: Provide insight into emerging neurodegenerative research, therapies, and care innovations that may inform ATCA’s evolving treatment model. Long-Term Care Perspective: Support strategies that balance clinical rigor, patient quality of life, and sustainable care delivery over extended disease timelines.

Why Join Us? Transform Patient Outcomes: Help advance a model of Alzheimer’s care that prioritizes early detection, prevention, and coordinated primary care involvement. Influence National Care Delivery: Play a meaningful role in shaping how primary care–informed cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where primary care leadership directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.